Skip to main
We’re doing some system maintenance
  1. Home
  2. Stocks
  3. Innovate Biopharmaceuticals
INNT

Buy Innovate Biopharmaceuticals (INNT) Stock

INNT
See INNT stock price and Buy/Sell Innovate Biopharmaceuticals with any amount of money. Discuss news and analyst's price prediction with the investor community. Enter your cell phone number to get started.
INNT

Innovate Biopharmaceuticals (INNT)

We couldn’t load this chart.

Some stock charts might currently not be supported. To try again, please refresh this page.

About Innovate Biopharmaceuticals (INNT)

9 Meters Biopharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on rare and unmet needs in gastroenterology. Its pipeline includes drug candidates for short bowel syndrome (SBS), celiac disease, and three early-stage candidates for undisclosed rare diseases and/or unmet needs. The company is founded by Jay P. Madan and Kendyle Woodard in 2012 and is headquartered in Raleigh, ...Read more
Market Cap
$97.23M
1 Year High
$1.55
Volume
1 Year Low
$0.35
Price to Earnings Ratio
Open
Dividend Rate
High
Dividend Yield
Low

Community

People who own or watch INNT stock

Innovate Biopharmaceuticals Stock News

Innovate Biopharmaceuticals stock rating

What analysts recommend for INNT stock, on a scale from 1 (buy) to 5 (sell).
Buy
Sell
1

Innovate Biopharmaceuticals price target

What analysts think INNT will be worth
Low $0
High $4.50
Current $0
Target $4.50

Events

List of events that could affect INNT stock.
20Mar

Earnings data Q4 2019

07May

Earnings data Q1 2020

Innovate Biopharmaceuticals earnings

The value each share was expected to gain vs. the value that each share actually gained
0
-0.02
-0.04
-0.05
Q3 2021
Q4 2021
Q1 2022
Q2 2022

Expected EPS
Q2 2022
-$0.04
Actual EPS
Q2 2022

Buy Innovate Biopharmaceuticals (INNT) Stock

INNT
See INNT stock price and Buy/Sell Innovate Biopharmaceuticals with any amount of money. Discuss news and analyst's price prediction with the investor community. Enter your cell phone number to get started.

Community

People who own or watch INNT stock
  • Johnrok avatar
  • KBell1030 avatar
  • shivangsharma avatar
  • totoro avatar
  • maddog3241 avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency trading is provided by Apex Crypto LLC (“Apex Crypto”). Apex Crypto is not a registered broker-dealer or FINRA member and is not affiliated with Public Holdings or any of its subsidiaries. Cryptocurrencies are not securities and your cryptocurrency holdings are not FDIC or SIPC insured. Crypto trading involves a substantial risk of loss as there is significant volatility in the price of cryptocurrencies.

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.